share_log

Talaris Therapeutics Q3 EPS $(0.46) Down From $(0.32) YoY

Talaris Therapeutics Q3 EPS $(0.46) Down From $(0.32) YoY

Talaris Therapeutics第三季度每股收益为0.46美元,低于同比0.32美元
Benzinga Real-time News ·  2022/11/10 07:10

Talaris Therapeutics (NASDAQ:TALS) reported quarterly losses of $(0.46) per share. This is a 43.75 percent decrease over losses of $(0.32) per share from the same period last year.

塔拉里斯治疗公司(纳斯达克代码:TALS)公布季度亏损为每股0.46美元。这比去年同期每股亏损0.32美元减少了43.75%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发